Federal award
KBR WYLE SERVICES, LLC
0010
Contract
Obligated and Ceiling
- Obligated (net)
- $14,160,449.35
- Ceiling (potential value, not spending)
- $15,397,519.00
- Current value
- $15,397,519.00
- Gross positive obligations
- $14,306,684.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · L693MQDFLKD1
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR WYLE SERVICES, LLC · TGPKTMN8YL31
- Awarding agency
- Department of Defense · sub-agency 5700 · office FA8075
- Funding agency
- Department of Defense · sub-agency 1700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
- PIID
- 0010
- Parent vehicle (IDV PIID)
- FA807514D0025
- Award type code
- C
- Actions
- 36 · Jun 7, 2016 to Aug 27, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History36
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Aug 27, 2025 | FY2025 | 35 | C | −$339.97 | |
| Mar 7, 2023 | FY2023 | 34 | C | −$145,894.68 | |
| Jan 26, 2022 | FY2022 | 33 | M | $0.00 | |
| May 6, 2021 | FY2021 | 32 | C | $280,000.00 | |
| Jan 22, 2021 | FY2021 | 31 | C | $225,000.00 | |
| Jan 8, 2021 | FY2021 | 30 | M | $0.00 | |
| Sep 28, 2020 | FY2020 | 29 | C | $75,000.00 | |
| Aug 26, 2020 | FY2020 | 28 | C | $1,600,000.00 | |
| Aug 5, 2020 | FY2020 | 27 | C | $250,000.00 | |
| Jul 6, 2020 | FY2020 | 26 | C | $110,000.00 | |
| Jun 12, 2020 | FY2020 | 25 | B | $0.00 | |
| Nov 12, 2019 | FY2020 | 24 | C | $297,000.00 | |
| Aug 19, 2019 | FY2019 | 23 | C | $600,000.00 | |
| Jul 23, 2019 | FY2019 | 22 | B | $0.00 | |
| Jun 14, 2019 | FY2019 | 21 | C | $110,000.00 | |
| Jun 5, 2019 | FY2019 | 20 | C | $20,000.00 | |
| Apr 24, 2019 | FY2019 | 19 | C | $1,850,000.00 | |
| Apr 2, 2019 | FY2019 | 18 | C | $150,000.00 | |
| Sep 25, 2018 | FY2018 | 17 | C | $21,828.00 | |
| Sep 24, 2018 | FY2018 | 16 | C | $344,855.00 | |
| Sep 7, 2018 | FY2018 | 15 | C | $1,815,689.00 | |
| Jul 19, 2018 | FY2018 | 14 | C | $329,024.00 | |
| Jun 11, 2018 | FY2018 | 13 | C | $1,810,000.00 | |
| May 14, 2018 | FY2018 | 12 | C | $150,000.00 | |
| Mar 27, 2018 | FY2018 | 11 | C | $40,000.00 | |
| Aug 17, 2017 | FY2017 | 10 | C | $110,000.00 | |
| May 30, 2017 | FY2017 | 9 | C | $2,159,913.00 | |
| May 11, 2017 | FY2017 | 8 | C | $0.00 | |
| Apr 10, 2017 | FY2017 | 7 | B | $0.00 | |
| Mar 23, 2017 | FY2017 | 6 | B | $0.00 | |
| Jan 4, 2017 | FY2017 | 5 | C | $25,000.00 | |
| Nov 9, 2016 | FY2017 | 4 | C | $30,000.00 | |
| Sep 21, 2016 | FY2016 | 3 | C | $0.00 | |
| Aug 24, 2016 | FY2016 | 2 | C | $1,050,000.00 | |
| Aug 15, 2016 | FY2016 | 1 | C | $110,000.00 | |
| Jun 7, 2016 | FY2016 | 0 | — | $743,375.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.